Table 1 Characteristics of study subjects
Characteristics | Uninfected population | Infected population |
|---|---|---|
N = 23 | N = 31 | |
Sex | ||
Male, N (%) | 9 (39.1) | 14 (45.2) |
Female, N (%) | 14 (60.9) | 17 (54.8) |
Age (years), median (range) | 53 (37–54) | 54 (47–56) |
Vaccine type | ||
BNT162b2 (PZ), N (%) | 7 (30.4) | 13 (40.6) |
mRNA-1273 (MO), N (%) | 16 (69.6) | 16 (50.0) |
Not defined, N (%) | 0 (0.0) | 2 (9.4) |